IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.75 EUR
+0 (+0.03%)
Taking everything into account, IVG scores 4 out of 10 in our fundamental rating. IVG was compared to 110 industry peers in the Machinery industry. There are concerns on the financial health of IVG while its profitability can be described as average. IVG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
Of the past 5 years IVG 4 years were profitable.
Each year in the past 5 years IVG had a positive operating cash flow.
1.2 Ratios
IVG has a Return On Assets (1.73%) which is in line with its industry peers.
IVG's Return On Equity of 12.39% is fine compared to the rest of the industry. IVG outperforms 73.64% of its industry peers.
IVG's Return On Invested Capital of 4.53% is in line compared to the rest of the industry. IVG outperforms 42.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.83%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG's Profit Margin of 2.17% is on the low side compared to the rest of the industry. IVG is outperformed by 61.82% of its industry peers.
IVG's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 5.00%, IVG is in line with its industry, outperforming 41.82% of the companies in the same industry.
IVG's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 16.49%, IVG is not doing good in the industry: 91.82% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
IVG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IVG has been increased compared to 5 years ago.
Compared to 1 year ago, IVG has an improved debt to assets ratio.
2.2 Solvency
IVG has an Altman-Z score of 1.77. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.77, IVG perfoms like the industry average, outperforming 42.73% of the companies in the same industry.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 14.82, IVG is not doing good in the industry: 71.82% of the companies in the same industry are doing better.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, IVG is not doing good in the industry: 82.73% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.3%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a Current ratio of 1.98. This is in the better half of the industry: IVG outperforms 74.55% of its industry peers.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.40, IVG is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased strongly by -23.43% in the last year.
The Earnings Per Share has been growing by 32.82% on average over the past years. This is a very strong growth
IVG shows a decrease in Revenue. In the last year, the revenue decreased by -7.24%.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
IVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.30% yearly.
EPS Next Y-19.44%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
EPS Next 5Y10.81%
Revenue Next Year-4.91%
Revenue Next 2Y1.21%
Revenue Next 3Y2.83%
Revenue Next 5Y4.3%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
IVG is valuated correctly with a Price/Earnings ratio of 13.99.
Compared to the rest of the industry, the Price/Earnings ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 81.82% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IVG to the average of the S&P500 Index (26.61), we can say IVG is valued slightly cheaper.
A Price/Forward Earnings ratio of 8.57 indicates a reasonable valuation of IVG.
Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 88.18% of the companies are valued more expensively.
IVG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.99 | ||
| Fwd PE | 8.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 80.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 68.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.71 | ||
| EV/EBITDA | 5.56 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y2.58%
EPS Next 3Y8.29%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.76%, IVG has a reasonable but not impressive dividend return.
IVG's Dividend Yield is a higher than the industry average which is at 1.55.
Compared to an average S&P500 Dividend Yield of 1.87, IVG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IVG pays out 27.33% of its income as dividend. This is a sustainable payout ratio.
DP27.33%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
BIT:IVG (12/23/2025, 3:55:00 PM)
18.75
+0 (+0.03%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners37.12%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.09B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (7.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.14%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-7.94%
EPS NY rev (3m)-9.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.64%
Revenue NY rev (3m)-2.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.99 | ||
| Fwd PE | 8.57 | ||
| P/S | 0.34 | ||
| P/FCF | 12.71 | ||
| P/OCF | 3.95 | ||
| P/B | 1.96 | ||
| P/tB | 9.21 | ||
| EV/EBITDA | 5.56 |
EPS(TTM)1.34
EY7.15%
EPS(NY)2.19
Fwd EY11.67%
FCF(TTM)1.47
FCFY7.87%
OCF(TTM)4.75
OCFY25.35%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.3%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-19.44%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-4.91%
Revenue Next 2Y1.21%
Revenue Next 3Y2.83%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year67.57%
EBIT Next 3Y28.42%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
Can you provide the valuation status for IVECO GROUP NV?
ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
What is the profitability of IVG stock?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
Can you provide the financial health for IVG stock?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
What is the earnings growth outlook for IVECO GROUP NV?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -19.44% in the next year.